HARBIN, China, Dec. 15 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company developing and producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that the Company has 30 medicines that will be included in the 2009 Edition of the National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Medicine Directory.
The 30 medicines treat a variety of common ailments and make up 17% of the Company's revenues for the first nine months of 2009. Nine of the medicines, including Salbutamol, Compound Sulfamethoxazole Tablets, Nitrofurantoin Enteric-coated Tablets, Amidopyrine and Phenacetin Compound Tablets, Isatis Root Granules, Pulse-activating Decoction, Compound Salvia Tablets, Guanxinsuhe Capsules, and Antibiotic and Liver Cholaneresis Soothing Tablets, are Category A medicines. Consumption of Category A drugs will be fully reimbursed by the national basic medical insurance system.
The 2009 Edition Directory includes a total of 2,151 medicines. There are 1,164 Western drugs in the Directory, including 349 Category A medicines, 791 Category B medicines, 20 restricted work injury insurance agents, and four maternity insurance agents. In addition, there are 987 Chinese medicines, including 154 Category A medicines and 833 Category B medicines.
"We are excited to have 30 medicines included in the 2009 Edition
Directory, which we expect to result in increased sales volumes for these
products as pharmacies in China make them widely available to meet demand from
patients," said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical.
"Few other pharmaceutical companies in China have accomplished this goal, and
|SOURCE China Sky One Medical, Inc.|
Copyright©2009 PR Newswire.
All rights reserved